NCT00738322View on ClinicalTrials.gov

To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

AZD1305

Solution for iv infusion, single dose

DRUG

Placebo

NaCl solution for iv infusion, single dose

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY